Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0015 Transporter Info
Gene Name	ABCC4
Transporter Name	Multidrug resistance-associated protein 4
Gene ID	10257
UniProt ID	O15439

Post-Translational Modification of This DT
Overview of ABCC4 Modification Sites with Functional and Structural Information
Sequence	M L P V Y Q E V K P N P L Q D A N L C S R V F F W W L N P L F K I G H K R R L E E D D M Y S V L P E D R S Q H L G E E L Q G F W D K E V L R A E N D A Q K P S L T R A I I K C Y W K S Y L V L G I F T L I E E S A K V I Q P I F L G K I I N Y F E N Y D P M D S V A L N T A Y A Y A T V L T F C T L I L A I L H H L Y F Y H V Q C A G M R L R V A M C H M I Y R K A L R L S N M A M G K T T T G Q I V N L L S N D V N K F D Q V T V F L H F L W A G P L Q A I A V T A L L W M E I G I S C L A G M A V L I I L L P L Q S C F G K L F S S L R S K T A T F T D A R I R T M N E V I T G I R I I K M Y A W E K S F S N L I T N L R K K E I S K I L R S S C L R G M N L A S F F S A S K I I V F V T F T T Y V L L G S V I T A S R V F V A V T L Y G A V R L T V T L F F P S A I E R V S E A I V S I R R I Q T F L L L D E I S Q R N R Q L P S D G K K M V H V Q D F T A F W D K A S E T P T L Q G L S F T V R P G E L L A V V G P V G A G K S S L L S A V L G E L A P S H G L V S V H G R I A Y V S Q Q P W V F S G T L R S N I L F G K K Y E K E R Y E K V I K A C A L K K D L Q L L E D G D L T V I G D R G T T L S G G Q K A R V N L A R A V Y Q D A D I Y L L D D P L S A V D A E V S R H L F E L C I C Q I L H E K I T I L V T H Q L Q Y L K A A S Q I L I L K D G K M V Q K G T Y T E F L K S G I D F G S L L K K D N E E S E Q P P V P G T P T L R N R T F S E S S V W S Q Q S S R P S L K D G A L E S Q D T E N V P V T L S E E N R S E G K V G F Q A Y K N Y F R A G A H W I V F I F L I L L N T A A Q V A Y V L Q D W W L S Y W A N K Q S M L N V T V N G G G N V T E K L D L N W Y L G I Y S G L T V A T V L F G I A R S L L V F Y V L V N S S Q T L H N K M F E S I L K A P V L F F D R N P I G R I L N R F S K D I G H L D D L L P L T F L D F I Q T L L Q V V G V V S V A V A V I P W I A I P L V P L G I I F I F L R R Y F L E T S R D V K R L E S T T R S P V F S H L S S S L Q G L W T I R A Y K A E E R C Q E L F D A H Q D L H S E A W F L F L T T S R W F A V R L D A I C A M F V I I V A F G S L I L A K T L D A G Q V G L A L S Y A L T L M G M F Q W C V R Q S A E V E N M M I S V E R V I E Y T D L E K E A P W E Y Q K R P P P A W P H E G V I I F D N V N F M Y S P G G P L V L K H L T A L I K S Q E K V G I V G R T G A G K S S L I S A L F R L S E P E G K I W I D K I L T T E I G L H D L R K K M S I I P Q E P V L F T G T M R K N L D P F N E H T D E E L W N A L Q E V Q L K E T I E D L P G K M D T E L A E S G S N F S V G Q R Q L V C L A R A I L R K N Q I L I I D E A T A N V D P R T D E L I Q K K I R E K F A H C T V L T I A H R L N T I I D S D K I M V L D S G R L K E Y D E P Y V L L Q N K E S L F Y K M V Q Q L G K A E A A A L T E T A K Q V Y F K R N Y P H I G H T D H M V T N T S N G Q P S T L T I F E T A L
PTM type	X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC4			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	807
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ABCC4 Lysine 807 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enhancing the activity of ABCC4			[2]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Prostaglandin E2	Results for Drug	Affecting the transport of prostaglandin E2
Modified Residue	Asparagine	Modified Location	746
Experimental Material(s)	Pig kidney epithelial (LLC-PK1) cells; Madin-darby canine kidney I (MDCKI) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCC4 Asparagine 746 have been reported to enhance its transport activity.
PTM Phenomenon 2	Enhancing the activity of ABCC4			[2]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Prostaglandin E2	Results for Drug	Affecting the transport of prostaglandin E2
Modified Residue	Asparagine	Modified Location	754
Experimental Material(s)	Pig kidney epithelial (LLC-PK1) cells; Madin-darby canine kidney I (MDCKI) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCC4 Asparagine 754 have been reported to enhance its transport activity.
PTM Phenomenon 3	Have the potential to influence ABCC4			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	651
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCC4 Asparagine 651 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCC4			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	690
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCC4 Asparagine 690 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCC4			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	792
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCC4 Asparagine 792 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCC4			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1176
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCC4 Asparagine 1176 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCC4			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1309
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCC4 Asparagine 1309 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC4			[4]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	171
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ABCC4 Cystine 171 has the potential to affect its expression or activity.
Phosphorylation
Serine	25 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC4			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	20
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 20 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCC4			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	79
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 79 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCC4			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	182
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 182 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCC4			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	260
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 260 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCC4			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	313
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 313 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCC4			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	314
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 314 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCC4			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	404
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 404 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCC4			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	563
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 563 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCC4			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	570
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 570 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCC4			[8] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	601
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 601 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCC4			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	623
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 623 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCC4			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	629
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 629 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCC4			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	638
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 638 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCC4			[15] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	655
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 655 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ABCC4			[15] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	657
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 657 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ABCC4			[15] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	658
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 658 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ABCC4			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	661
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 661 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ABCC4			[15] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	664
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 664 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ABCC4			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	665
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 665 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ABCC4			[15] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	668
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 668 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ABCC4			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	676
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 676 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence ABCC4			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	687
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 687 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence ABCC4			[21] , [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	692
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 692 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence ABCC4			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	804
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 804 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence ABCC4			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1241
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Serine 1241 has the potential to affect its expression or activity.
Threonine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC4			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	81
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 81 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCC4			[24]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 269 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCC4			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	281
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 281 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCC4			[25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	388
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 388 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCC4			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	434
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 434 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCC4			[26] , [27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	646
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 646 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCC4			[19] , [28]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	648
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 648 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCC4			[18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	653
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 653 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCC4			[15] , [29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	679
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 679 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCC4			[15] , [20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	685
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 685 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCC4			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	913
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 913 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCC4			[30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1130
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 1130 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCC4			[23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 1227 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCC4			[23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1230
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 1230 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ABCC4			[23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1237
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Threonine 1237 has the potential to affect its expression or activity.
Tyrosine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC4			[5] , [31]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	5
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Tyrosine 5 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCC4			[32]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	45
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Tyrosine 45 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCC4			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	550
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Tyrosine 550 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCC4			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	556
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Tyrosine 556 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCC4			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1016
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Tyrosine 1016 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCC4			[33]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Tyrosine 1255 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCC4			[8] , [34]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1259
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC4 Tyrosine 1259 has the potential to affect its expression or activity.
Ubiquitination
Lysine	23 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	66
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 66 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	77
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 77 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	264
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 264 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	293
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 293 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	304
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 304 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	515
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 515 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	540
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 540 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	607
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 607 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	614
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 614 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	622
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 622 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	632
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 632 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	633
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 633 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	670
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 670 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	695
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 695 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	702
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 702 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1021
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 1021 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1070
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 1070 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1165
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 1165 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1253
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 1253 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1265
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 1265 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1271
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 1271 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1278
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 1278 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1289
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Lysine 1289 has the potential to affect its expression or activity.
Phenylalanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC4			[35] , [36]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	627
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC4 Phenylalanine 627 has the potential to affect its expression or activity.

References
1	The impact of walking speed on the kinetic behaviour of different foot joints. Gait Posture. 2019 Feb;68:375-381.
2	N-linked glycans do not affect plasma membrane localization of multidrug resistance protein 4 (MRP4) but selectively alter its prostaglandin E2 transport activity. Biochem Biophys Res Commun. 2016 Jan 22;469(4):954-9.
3	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: MRP4_HUMAN)
4	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
5	Selective Enrichment of Cysteine-Containing Phosphopeptides for Subphosphoproteome Analysis. J Proteome Res. 2015 Dec 4;14(12):5341-7.
6	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
7	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
9	Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column. Anal Sci. 2008 Jan;24(1):161-6.
10	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
11	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
12	Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. Proteomics. 2008 May;8(10):2024-34.
13	Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H. Int J Mol Sci. 2015 Feb 16;16(2):4209-25.
14	Modulation of the chromatin phosphoproteome by the Haspin protein kinase. Mol Cell Proteomics. 2014 Jul;13(7):1724-40.
15	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
16	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
17	Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells. PLoS One. 2018 Jul 12;13(7):e0199349.
18	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
19	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
20	Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
21	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
22	Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
23	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
24	Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics. 2013 Oct 8;91:286-96.
25	Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics. Cell Rep. 2016 Apr 12;15(2):436-50.
26	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
27	The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 Aug 6;182(3):685-712.e19.
28	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
29	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
30	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
31	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
32	Inactivation and lysis of oncornaviruses by human and primate complement. Haematol Blood Transfus. 1979;23:501-3.
33	Induction of concentration-dependent blockade in the G2 phase of the cell cycle by cancer chemotherapeutic agents. Cancer Res. 1978 Mar;38(3):809-14.
34	Breakage of DNA and alterations in folded genomes by inducers of differentiation in Friend erythroleukemic cells. Cancer Res. 1978 Mar;38(3):841-9.
35	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
36	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence